-
Learning Medicare’s ABCDs
Medicare was established to help provide affordable health care coverage for older Americans. But Medicare beneficiaries with cancer can still face financial burdens related to their care.
by Kate Yandell
-
Planning to Survive
Survivorship care plans can prepare cancer patients to get the best medical care and maintain their quality of life following treatment.
by Carly Flumer
-
Targeted Therapy for Early-Stage Lung Cancer?
A trial of the targeted therapy Tagrisso (osimertinib) for early-stage lung cancer finds that patients who take it go longer without having a cancer recurrence. Whether that should change clinical practice is under discussion.
by Ashley P. Taylor
-
Cervical Cancer Screening Guideline Updated
A new version of the American Cancer Society's cervical cancer screening guideline says screening can start at a later age and highlights human papillomavirus testing as the preferred method.
by Anna Azvolinsky
-
A Missed Conversation
Despite national guidelines urging oncologists to bring up risks of infertility posed by cancer treatment, many young cancer patients are never told about these risks or counseled on their fertility preservation options.
by Marcus A. Banks
-
Anal Cancer Diagnoses and Deaths Are Rising in the U.S.
Study underscores importance of early detection and prevention.
by Jane Langille
-
The Pandemic’s Impact on Cancer Screening and Detection
Delays in cancer screening and diagnosis due to the COVID-19 pandemic put people at risk.
by Kevin McLaughlin
-
The Return to Work
What happens if your workplace reopens before you're ready to return or you're an essential worker? For some people who have been diagnosed with cancer, accommodations may be possible.
by Jen Tota McGivney
-
Forward Look
Here Come the BiosimilarsAs patents expire on biologic drugs, cancer patients get new options.
by Stephen Ornes
-
Forward Look
More Treatments Approved for Metastatic Breast CancerTargeted therapy approvals increase options and hope for some patients.
by Cameron Walker
Cancer Talk
Can Steroids Impair Immunotherapy for Cancer?
A new study suggests steroids could blunt the effects of some immunotherapies, but researchers say they remain necessary for some patients.
by Kyle Bagenstose
Treatment Combination Improves Survival in Platinum-resistant Ovarian CancerPreliminary results found that combining relacorilant with nab-paclitaxel improved outcomes for women with advanced ovarian cancer.
by Sandra Gordon
CAR T-cell Therapy Shows Response in Rare Brain CancerPotential new approach to treating diffuse intrinsic pontine glioma uses engineered immune cells infused directly to the brain.
by Taneia Surles
Technology’s Changing Role in Cancer CareExperts explain how artificial intelligence, nanotechnology and decentralized care are poised to improve research, detection and treatment.
by Thomas Celona